FindTrial
Sign In

“Regeneración del disco intervertebral lumbar mediante MSV*” *Células progenitoras de médula ósea autóloga, expandidas “Ex Vivo” con procedimiento GMP del Instituto de Biología y Genética Molecular de Valladolid

“Regeneración del disco intervertebral lumbar mediante MSV*” *Células progenitoras de médula ósea autóloga, expandidas “Ex Vivo” con procedimiento GMP del Instituto de Biología y Genética Molecular de Valladolid

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-001191-68-ES
Enrollment
Unknown
Registered
2008-08-04
Start date
2008-11-10
Completion date
Unknown
Last updated
2012-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pacientes con enfermedad degenerativa de uno o dos discos lumbares con predominio de dolor lumbar y/o citalagia persistente tras tratamiento conservador (médico y fisioteràpico) de mas de 6 meses de evolución.

Interventions

Product Name: MSV Pharmaceutical Form: Living tissue equivalent INN or Proposed INN: MSV Concentration unit: U unit(s) Concentration type: range Concentration number: 10.000.000-40.000.000

Sponsors

Institut de Terapia Regenerativa Tissular (ITRT)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Spain

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026